Type of Oral Contraceptive Pills in Patients with Complete ACL Tears: A Retrospective Study
Keywords:ACL tears, estrogen, oral contraceptives
Purpose: Differences in sex hormones are one of the proposed mechanisms for the increased risk of anterior cruciate ligament (ACL) injury in female athletes. Oral contraceptive pills (OCPs) may reduce the risk of ACL injuries in females, but the effects of different types of OCPs have not been examined. This study aimed to investigate the type of OCPs used in women diagnosed with ACL tears. We hypothesized that a greater proportion of women with ACL tears will be exposed to OCPs containing high estrogen and less androgenic progestins than other types of OCPs. Methods: Medical records from Hospital for Special Surgery (New York, NY) for women ages 16-55 with diagnosis of an ACL tear while concurrently taking OCPs were reviewed from January 2016 to June 2018 for demographic data, documentation of ACL injury, type of OCP at time of injury, ethinyl estrogen dose, and progestin dose. OCP androgenicity was determined by multiplying the dose of progestin by the progestin’s androgenicity. Results: A total of 223 patients sustained an ACL tear while taking OCPs. The most commonly used OCP was a high estrogen/low androgenicity progestin pill (107/223=48%).When each hormone was considered individually, the majority of women were exposed to OCPs with high estrogen (58.7% vs 41.3%, p<0.0001) and low androgenicity progestin (84.8% vs 15.3%, p<0.0001). Conclusion: A large portion of women who sustained ACL tears were taking a high estrogen/low androgenicity progestin OCP at the time of injury and this is different than population data where the majority of women are exposed to moderately high androgenicity progestins. Future studies should be conducted to determine if OCPs with high estrogen and low androgenicity progestin correlate with increased risk of ACL injury.
Copyright (c) 2022 Brittany Ammerman, Jennifer Cheng, Daphne Ling, Ellen Casey
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright, simultaneously licensing their works under a Creative Commons Attribution 4.0 International License (CC BY 4.0). That license allows others to share and adapt the work so long as they provide reasonable attribution. This license applies to the submitted version of the work (preprint), the accepted version of the work (postprint), and the final published version.
Ideal attribution for a work published in this journal consists of the work’s title, the title of the journal, the name(s) of the author(s), the DOI (digital object identifier), and a link to the CC BY 4.0 license deed. The journal encourages those relying on the CC BY 4.0 license to consult the Best Practices for Attribution on the Creative Commons wiki.
As they retain copyright, authors are entitled to distribute any version of the article and to grant other licenses to use the work, subject to the CC BY 4.0 license. The journal encourages authors to include the ideal attribution described above when they distribute their works after acceptance by the journal.
Authors are encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and after publication, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see SPARC's "Open Access" article).